Jasminka Vukanovic
About
In The Last Decade
Jasminka Vukanovic
9 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 798
- Pulmonary and Respiratory Medicine 409
- Oncology 327
- Cancer Research 275
- Immunology and Allergy 254
Countries citing papers authored by Jasminka Vukanovic
This map shows the geographic impact of Jasminka Vukanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasminka Vukanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasminka Vukanovic more than expected).
Fields of papers citing papers by Jasminka Vukanovic
This network shows the impact of papers produced by Jasminka Vukanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasminka Vukanovic. The network helps show where Jasminka Vukanovic may publish in the future.
Co-authorship network of co-authors of Jasminka Vukanovic
This figure shows the co-authorship network connecting the top 25 collaborators of Jasminka Vukanovic. A scholar is included among the top collaborators of Jasminka Vukanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasminka Vukanovic. Jasminka Vukanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 22 | |
| 3 | Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. | 46 |
| 4 | 34 | |
| 5 | KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2 breakdown → | 645 |
| 6 | Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide. | 46 |
| 7 | Implication of cell kinetic changes during the progression of human prostatic cancer. | 287 |
| 8 | Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. | 93 |
| 9 | Antiangiogenic effects of the quinoline-3-carboxamide linomide. | 91 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.